# Latino Semaglutide Study

> **NCT05087342** · PHASE3 · COMPLETED · sponsor: **Loma Linda University** · enrollment: 119 (actual)

## Conditions studied

- Obesity
- Obesity; Drug
- Overweight or Obesity
- Weight Loss
- Weight Loss Trajectory
- Weight, Body

## Interventions

- **DRUG:** Semaglutide 2.4mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05087342
- **Lead sponsor:** Loma Linda University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-13
- **Primary completion:** 2024-05-29
- **Final completion:** 2024-05-29
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2024-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05087342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05087342, "Latino Semaglutide Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05087342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*